These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

473 related items for PubMed ID: 6848603

  • 41. Induction of cytolytic activity and interferon-gamma production in murine natural killer cells by polymyxins B and E.
    Zhong M, Kadota Y, Shimizu Y, Gohda E.
    Int Immunopharmacol; 2008 Mar; 8(3):508-13. PubMed ID: 18279806
    [Abstract] [Full Text] [Related]

  • 42. Correlation of immunomodulatory and therapeutic activities of interferon and interferon inducers in metastatic disease.
    Black PL, Phillips H, Tribble HR, Pennington R, Schneider M, Talmadge JE.
    J Cell Biochem; 1988 Apr; 36(4):377-92. PubMed ID: 3132467
    [Abstract] [Full Text] [Related]

  • 43. Absence of major histocompatibility complex class I on neural stem cells does not permit natural killer cell killing and prevents recognition by alloreactive cytotoxic T lymphocytes in vitro.
    Mammolenti M, Gajavelli S, Tsoulfas P, Levy R.
    Stem Cells; 2004 Apr; 22(6):1101-10. PubMed ID: 15536199
    [Abstract] [Full Text] [Related]

  • 44. Studies on natural killer (NK) cells. I. NK cell specific antibodies in CE anti-CBA serum.
    Burton RC, Winn HJ.
    J Immunol; 1981 May; 126(5):1985-9. PubMed ID: 7217676
    [Abstract] [Full Text] [Related]

  • 45. Modulation of murine natural killer cell activity in vitro and in vivo by recombinant human interferons.
    Brunda MJ, Rosenbaum D.
    Cancer Res; 1984 Feb; 44(2):597-601. PubMed ID: 6692364
    [Abstract] [Full Text] [Related]

  • 46. Variation of interferon induction at the bone marrow level. Studies on interferon induction in relation to natural cell-mediated cytotoxic mechanisms.
    Orn A, Gidlund M, Wigzell H, Gresser I.
    Eur J Immunol; 1981 Oct; 11(10):795-9. PubMed ID: 6171433
    [Abstract] [Full Text] [Related]

  • 47. Studies on natural killer (NK) cells. II. Serologic evidence for heterogeneity of murine NK cells.
    Burton RC, Bartlett SP, Kumar V, Winn HJ.
    J Immunol; 1981 Nov; 127(5):1864-8. PubMed ID: 6975301
    [Abstract] [Full Text] [Related]

  • 48. NK 1+ CD4- CD8- alphabeta T cells in the peritoneal cavity: specific T cell receptor-mediated cytotoxicity and selective IFN-gamma production against B cell leukemia and myeloma cells.
    Sugie T, Kubota H, Sato M, Nakamura E, Imamura M, Minato N.
    J Immunol; 1996 Nov 01; 157(9):3925-35. PubMed ID: 8892624
    [Abstract] [Full Text] [Related]

  • 49. IFN-gamma production and degranulation are differentially regulated in response to stimulation in murine natural killer cells.
    Vahlne G, Becker S, Brodin P, Johansson MH.
    Scand J Immunol; 2008 Jan 01; 67(1):1-11. PubMed ID: 18028287
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Th1 cytokines and NK cells participate in the development of murine syngeneic graft-versus-host disease.
    Flanagan DL, Jennings CD, Bryson JS.
    J Immunol; 1999 Aug 01; 163(3):1170-7. PubMed ID: 10415011
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Cytolytic activity of murine CD4+ T cell clones correlates with IFN-gamma production in mouse strains having a BALB/c background.
    McKisic MD, Lancki DW, Fitch FW.
    J Immunol; 1993 May 01; 150(9):3793-805. PubMed ID: 8097225
    [Abstract] [Full Text] [Related]

  • 54. Expansion of natural killer cells in mice transgenic for IgM antibody to ganglioside GD2: demonstration of prolonged survival after challenge with syngeneic tumor cells.
    Kawashima I, Yoshida Y, Taya C, Shitara H, Yonekawa H, Karasuyama H, Tada N, Furukawa K, Tai T.
    Int J Oncol; 2003 Aug 01; 23(2):381-8. PubMed ID: 12851687
    [Abstract] [Full Text] [Related]

  • 55. IL-18 augments perforin-dependent cytotoxicity of liver NK-T cells.
    Dao T, Mehal WZ, Crispe IN.
    J Immunol; 1998 Sep 01; 161(5):2217-22. PubMed ID: 9725214
    [Abstract] [Full Text] [Related]

  • 56. The selective growth of murine newborn-derived suppressor cells and their probable mode of action.
    Jadus MR, Parkman R.
    J Immunol; 1986 Feb 01; 136(3):783-92. PubMed ID: 2934478
    [Abstract] [Full Text] [Related]

  • 57. Characterization of early IL-12, IFN-alphabeta, and TNF effects on antiviral state and NK cell responses during murine cytomegalovirus infection.
    Orange JS, Biron CA.
    J Immunol; 1996 Jun 15; 156(12):4746-56. PubMed ID: 8648121
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. The NK-1.1(-) mouse: a model to study differentiation of murine NK cells.
    Koo GC, Dumont FJ, Tutt M, Hackett J, Kumar V.
    J Immunol; 1986 Dec 15; 137(12):3742-7. PubMed ID: 3782794
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.